Preparation method for curcumin long circulating liposomes

Abstract

Provided is a preparation method for curcumin long circulating liposomes. The method comprises steps: curcumin, soybean lecithin, cholesterol and polyethylene glycol- distearoyl phosphatidyl ethanolamine are weighed in a mass ratio of 1:30-50:3-5:1-3; the above raw materials are dissolved in ethanol as an organic phase; a phosphate buffer salt solution with a pH value of 6-7 is taken as an aqueous phase; under a rotating speed of 1000-1500 r / min, the organic phase is dropwisely added in the organic phase with thermal insulation at the temperature of 40-50 DEG C slowly and at a constant speed; after the dropwise add, stirring is continued for 2-3h, the organic solvent is volatilized, and a solution of the curcumin long circulating liposomes is obtained. The beneficial effects of the preparation method are mainly that, Cur-LCL is prepared through ethanol injection method, the technology is simple, the entrapment rate is high, the particle sizes are small, the release in vitro is slow, and the in vivo pharmacokinetics data display that the plasma clearance is decreased obviously, the half-life period is remarkably prolonged, and the curcumin long circulating liposomes have certain long circulation effects.

Description

technical field [0001] The invention relates to a preparation method of curcumin long-circulation liposome. Background technique [0002] Curcumin (Cur) is the main active ingredient of the traditional Chinese medicine turmeric, which belongs to polyphenolic compounds. Modern research has clearly proved that it has various pharmacological effects such as anti-tumor, anti-inflammation, and anti-oxidation, and has small toxic and side effects. It has clinical application prospects good. However, due to the poor water solubility of curcumin, it is easily oxidized, the metabolism is rapid in the body, and the defects of low bioavailability limit the popularization and development of curcumin. Liposomes, as a new drug delivery system, have the advantages of targeting, sustained release, reducing drug toxicity and improving drug stability. However, the action time of ordinary liposomes as a drug carrier is still not ideal, and the long-term storage is easy to aggregate and the s...

AI Technical Summary

Problems solved by technology

However, as a drug carrier, the action time of common liposomes is still not ideal, and the long-term storage is easy to aggregate and the stability is not good

Images